Partners

Multi-Omics Laboratory Network

To support a project of this scale, we've established a globally distributed laboratory infrastructure purpose-built for high-throughput, standardised, and interoperable multi-omics analysis.

Each certified lab in our network adheres to harmonised protocols and advanced quality control systems—enabling seamless integration of data across borders while maintaining scientific integrity at every step.

Scientific Leaders

The 1M-PI is guided by some of the world’s most influential pioneers in Systems Biology & AI-driven healthcare.

Our scientific leadership brings together decades of experience across multi-omics, computational biology, translational medicine, and global health strategy—ensuring that every aspect of the initiative is rooted in rigorous science, ethical governance, and visionary thinking.

Scaling Global Sample Processing Capacity

These labs standardise processing across all sample types (blood, stool, saliva), using validated pipelines for omics integration and AI-readiness.

Our Scientific Leaders

Prof. Adil Mardinoglu

Founder & CEO, Phenome Longevity. Professor at King’s College London & KTH - Royal Institute of Technology.

Dr. Vishnuvardhan Srinivasulu

Founder & CEO, Vizzhy Longevity

Prof. Minho Shong

Founder & CEO, SILK Longevity. Professor at Korea Advanced Institute of Science & Technology (KAIST)

Prof. Leroy Hood

Founder & CEO, Phenome Health. Professor at Institute of Systems Biology.

Prof. Mathias Uhlén

Professor at KTH - Royal Institute of Technology & Karolinska Institute.

Prof. Bernhard O. Palsson

Founder & CEO, Pasteur21. Professor at University of California San Diego (UCSD)

Prof. Hasan Turkez

Professor at Atatürk University.

Prof. Jens Nielsen

CEO at BioInnovation Institute. Professor at Chalmers University Of Technology

Dr. Hakan Sakul

Former VP of Diagnostics at Pfizer. Founder & CEO, Precision Dx.

Clinical & Hospital Partners

Anchored in Real-World Health Systems

Each partner contributes to patient recruitment, clinical data collection, and protocol implementation.

United States

  • University of Pittsburgh Medical Center (UPMC) – 40+ hospitals

Europe & Turkiye

  • Atatürk University Hospital (Erzurum)
  • Akdeniz University Hospital (Antalya)
  • Acıbadem Healthcare Group – 29 hospitals in Turkiye, Netherlands & Bulgaria

India

  • Manipal Hospitals – 40+ hospitals

South Korea

  • Seoul National University Hospital
  • Severance Hospital, Yonsei University
  • St. Mary’s Hospital
  • Inje University Hospital Group
  • Soonchunhyang University Hospital

Industry & Pharma Collaboration

Driving Innovation Through Open Science & Shared Value

De-identified longitudinal multi-omics data & clinical data

AI & Systems Biology Based Model Development & Validation

Biomarker & Drug Target Discovery for Development of Effective Treatment Strategies

Transforming Clinical Trials Using Multi-Omics Data to Add Molecular Depth to Conventional Endpoints

Become a Partner

Join the World’s Most Ambitious Health Study

The 1M-PI is forging a new paradigm in healthcare—powered by science, scale, and global collaboration. We are actively seeking visionary partners who share our commitment to advancing precision health. Opportunities for collaboration include:

  • Academic institutions advancing systems medicine and translational researc
  • Hospitals and clinical networks contributing diverse patient populations and clinical expertise
  • Pharmaceutical companies driving innovation in drug discovery and personalized therapies
  • AI and technology partners developing cutting-edge analytical tools and platform
  • Government bodies and global health organizations shaping policy and promoting equitable access
Contact US